Table 1 Characteristics of the Study Population
From: Impact of diabetes mellitus on epithelial ovarian cancer survival
|  | Diabetic Patients (n = 37) | Nondiabetic Patients (n = 178) | P-value |
|---|---|---|---|
Age at diagnosis (year)a | 65.35 ± (10.13) | 61.30 ± (8.87) | 0.015 |
Follow-upa | 27.97 ± (13.00) | 41.01 ± (14.62) | < 0.001 |
BMIa | 28.10 ± (2.25) | 25.47 ± (1.87) | < 0.001 |
Paritya | 4.45 ± (3.06) | 2.05 ± (2.50) | < 0.001 |
Neoadjuant chemotherapyb | |||
 Yes | 3(8.1) | 10(5.6) | 0.563 |
 No | 34(91.9) | 168(94.4) | |
Menopausal statusb | |||
 Premenopausal | 10(27) | 83(46.6) | 0.029 |
 Postmenopausal | 27(73) | 95(53.4) | |
Stageb | |||
 I | 1(2.7) | 18(10.1) | 0.047 |
 II | 3(8.1) | 42(23.6) | |
 III | 30(81.1) | 110(61.8) | |
 IV | 3(8.1) | 8(4.5) | |
Gradeb | |||
 1 | 10(27) | 107(60.1) | 0.001 |
 2 | 15(40.5) | 38(21.3) | |
 3 | 12(32.5) | 33(18.5) | |
Histologyb | |||
 Serous | 26(70.3) | 103(57.9) | 0.482 |
 Mucinous | 6(16.2) | 41(23) | |
 Endometrioid | 4(10.8) | 16(9) | |
 Clear | 1(2.7) | 17(9.6) | |
 Transitional | 0(0) | 1(0.6) | |
Debulking statusb | |||
 Optimal | 14(37.8) | 139(78.5) | < 0.001 |
 Suboptimal | 23(62.2) | 37(20.9) | |
 Unknown | 0(0) | 1(0.6) | |
HTN | |||
 Yes | 10(27) | 28(15.7) | 0.101 |
 No | 27(73) | 150(84.3) | |